Tuesday, June 17, 2025
Tags Managing Director of Supriya Lifescience Ltd Dr Saloni Wagh

Tag: Managing Director of Supriya Lifescience Ltd Dr Saloni Wagh

Supriya Lifescience Reports Robust Q1 FY25 Results with 21.7% Revenue Growth and Enhanced Profit Margins

Mumbai : The financial statements for the first quarter of Q1 FY 25 have been released by Supriya Lifescience Ltd., a cGMP-compliant business with...
- Advertisment -
newspaper

Most Read